Brought to you by 
Amplyx closes Series A round led by Life Science Angels
28 Apr 2021
Executive Summary
Amplyx Pharmaceuticals (developing small molecules with better profiles than existing drugs) raised $781k in its Series A financing led by Life Science Angels, which contributed $492k. Tech Coast Angels added the remaining money.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- ADMET
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amplyx closes Series A round led by Life Science Angels
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice